treatment
purifi
bovin
coronaviru
mebu
strain
pronas
destroy
integr
virion
surfac
glycoprotein
reduc
amount
destroy
hemagglutin
activ
viru
bromelain
hand
destroy
integr
fail
remov
fail
destroy
viral
hemagglutin
activ
experi
suggest
virion
hemauti
ioblot
studi
use
monospecif
antiserum
demonstr
suld
dimer
structur
reduc
monom
kda
bovin
coronaviru
hemagglutinin
bromelain
resist
hemautin
noeutat
mammalian
coronavirus
identifi
mcintosh
sever
mammalian
coronavirus
classifi
basi
antigen
related
found
hemagglutin
coronavirus
could
class
one
two
major
antigen
subgroup
although
virus
within
subgroup
hemagglutin
properti
pederson
et
al
includ
subgroup
hemagglutin
bovin
enter
coronaviru
porcin
hemagglutin
encephalomyel
viru
hemautin
human
respiratori
coronaviru
noemauat
mous
hepat
viru
paper
report
molecul
respons
hemagglutin
bovin
coronaviru
appar
one
four
surfac
rosn
exist
disulfidelink
dimer
two
glycoprotein
plaqu
purifi
bovin
coronaviru
mebu
strain
grown
either
bovin
embryo
kidney
cell
line
inaba
et
al
human
rectal
tumor
cell
line
tompkin
et
al
describ
king
brian
viru
grown
either
cell
line
virtual
ident
judg
electrophoret
profil
viral
protein
viru
purifi
isopycn
sediment
describ
king
brian
solubil
tri
hcl
ph
urea
electrophores
method
kaemmli
immunoblot
method
towbin
et
al
modifi
bumett
except
protein
transfer
nitrocellulos
gradient
v
h
nitrocellulos
wash
buffer
consist
mm
nacl
mm
edtaso
mm
trishcl
ph
tritonol
sd
antiserum
prepar
immun
separ
rabbit
pg
sdspolyacrylamid
gelpurifi
combin
respect
protein
use
immun
prepar
viru
purifi
isopycn
ratezon
sediment
previous
describ
king
brian
polyacrylamid
plug
contain
isol
protein
minc
divid
three
portion
amino
acidlabel
bcv
purifi
describ
king
brian
one
third
incub
tmn
buffer
mm
tri
acid
maleat
ph
mm
nacl
h
resedi
isopycn
panel
one
third
incub
tmn
contain
mgml
bromelain
sigma
chemic
co
mm
dithiothreitol
h
c
modifi
procedur
compan
et
al
resedi
isopycn
panel
b
one
third
treat
pronas
h
previous
describ
king
brian
resedi
isopycn
panel
c
buoyant
densiti
determin
refract
index
fraction
aliquot
fraction
assay
acidprecipit
radioact
hemagglutin
activ
peak
fraction
gradient
separ
pool
analyz
electron
microscopi
gel
electrophoresi
portion
emulsifi
pg
nacetylmuramyllalanyl
soglutamin
calbiochem
prior
subcutan
inject
singl
portion
amount
inject
week
interv
serum
dilut
immunoblot
experi
antisera
use
separ
immunoblot
experi
antiserum
prepar
react
nonreduc
condit
includ
solubil
buffer
fig
data
shown
preiun
serum
react
protein
immun
serum
react
protein
uninfect
cell
data
shown
therefor
behav
monomer
dimer
form
polypeptid
support
tent
conclus
made
earlier
report
king
brian
tri
differ
proteas
remov
extern
protein
bcv
observ
bromelaintr
viru
still
hemagglutin
mous
erythrocyt
wherea
pronas
complet
destroy
activ
fig
hemagglutin
titer
bromelaintr
viru
observ
nine
experi
rang
observ
equal
amount
untreat
viru
enzym
decreas
buoyant
densiti
viru
approm
howev
fig
sinc
pronas
shown
remov
drastic
reduc
surfac
glycoprotein
virion
king
brian
bromelaintr
pronasetr
viru
analyz
electrophoresi
parallel
determin
protein
might
respons
hemagglutin
viru
radiolabel
amino
acid
purifi
describ
king
brian
divid
equal
variou
treatment
resedi
isopycn
fig
electrophoret
analysi
particl
peak
region
gradient
reveal
bromelain
treatment
alter
integr
glycoprotein
except
viru
eltrophor
left
intern
protein
intact
fig
molar
amount
rel
intern
remain
bromelain
treatment
tabl
addit
sever
poli
peptid
migrat
faster
appear
bromelain
treatment
resembl
observ
pronas
treatment
king
brian
fig
l
name
minor
kda
speci
broad
band
polypeptid
region
kda
abund
kda
speci
interpret
envelopeassoci
digestionresist
fragment
basi
size
alon
appear
repres
nearli
portion
molecul
regardless
enzym
use
experiment
need
determin
exact
origin
speci
howev
data
along
demonstr
surfac
glycoprotein
king
brian
suggest
bvc
hemagglutinin
electron
microscopi
reveal
purifi
untreat
virion
irregularli
space
larg
bulbou
peplom
previous
report
king
brian
bromelaintr
vuion
appear
fring
short
project
fig
short
project
may
structur
counterpart
may
also
repres
bromelain
resist
fragment
glycoprotein
speci
project
two
differ
size
report
bovin
coronaviru
bridger
et
al
increas
hemagglutin
follow
bromelain
digest
could
explain
remov
larg
peplom
steric
interfer
interact
erythrocyt
hemagglutinin
consist
hemagglutinin
protein
find
antigenit
relat
hemagglutin
encephalomyel
viru
unpublish
data
hemagglutin
human
coronaviru
hogu
et
al
also
contain
antigen
relat
molecul
behav
disulfidelink
dimer
kda
molecul
nonhemagglutin
mous
hepat
coronaviru
hand
molecular
counterpart
evidenc
direct
electrophoret
analysi
immunoblot
studi
use
rabbit
serum
employ
experi
describ
fig
hogu
et
al
report
callebaut
pensaert
also
describ
kda
disulfidelink
dimer
glycoprotein
hemagglutin
encephalomyel
viru
swine
semipurifi
form
interfer
hemagglutin
viru
experi
also
suggest
kda
glycoprotein
function
hemagglutinin
molecul
interestingli
studi
callebaut
pensaert
bromelain
destroy
hemagglutin
properti
viru
suggest
may
distinct
structur
differ
bcv
porcin
hemagglutin
encephalomyel
viru
bromelain
univers
remov
surfac
project
envelop
virus
resist
one
peplom
observ
paryxoru
chen
et
al
porcin
transmiss
gastroenter
viru
garw
pocock
human
coronaviru
hierholz
et
al
perhap
bromelain
sensit
coronaviru
hemagglutinin
common
featur
use
classifi
coronavirus
insensit
bcv
digest
studi
due
idiosyncrasi
one
specif
lot
enzym
sinc
result
obtain
use
two
separ
lot
experi
demonstr
inhibit
hemagglutin
monospecif
antiserum
prepar
togeth
success
may
due
fact
epitop
erythrocyt
bind
destroy
denatur
prepar
antiserum
product
sinc
antiserum
prepar
sdstreat
whole
viru
likewis
inhibit
hemautin
hogu
bg
king
b
brian
da
antigen
relationship
among
protein
bovin
coronaviru
human
respiratori
coronaviru
mous
hepat
coronaviru
j
virol
inaba
sato
k
kurogi
h
takahashi
